⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
HiberCell to Present Preliminary Results from the Phase 1b Trial of GCN2 Activator HC-7366 when Combined with WELIREG® (belzutifan) for the Treatment of Late-Line Clear Cell Renal Cell Carcinoma (ccRCC) at the Upcoming 2026 ASCO Annual Meeting
globenewswire.com
MRK
Marquee Brands stringe una partnership strategica con DAMAC Group acquisendo una quota di maggioranza in Roberto Cavalli
businesswire.com
MRK
Marquee Brands nawiązuje strategiczne partnerstwo z DAMAC Group w celu objęcia udziału większościowego w firmie Roberto Cavalli
businesswire.com
MRK
RBC
NMDP Gala in New York City Raises Record-Breaking $660,000 Enabling More Patients to Receive Life-Saving Cell Therapy
globenewswire.com
SNY
MSB
AMZN
MRK
Cutaneous T-Cell Lymphoma Clinical Trial Pipeline Accelerates as 30+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight
globenewswire.com
SNGX
IPHA
BMY
NKTX
AZN
MRK
TAK
NVS
GMAB
ABBV
BIIB
CRSP
INCY
ALKS
PFE
REGN
GILD
AMGN
MilliporeSigma Launches Supplier Sustainability Toolkits to Help Advance Supply Chain Impact
accessnewswire.com
MRK
Sieben Alexander, P.A. Secures $10.2M Verdict for Twin Cities Family Against Cosmetic Talc Manufacturers
prnewswire.com
JNJ
MRK
TGT
WMT
Hepatitis A Market Research Report 2026-2036: Ecosystem, Marketed and Emerging Therapies, Epidemiological Analysis, Pipeline, Clinical Trial Landscape, Regulations Featuring GSK, Merck, and Sanofi
globenewswire.com
GSK
MRK
SNY
Late-Stage Chronic Kidney Disease Market Analysis Report 2026-2036, Profiles of Key Players - Novartis, Merck & Co, Pfizer, Sanofi, and Johnson & Johnson
globenewswire.com
AMGN
FMS
DVA
ABBV
NVS
MRK
PFE
SNY
JNJ
Oligometastatic Disease Market Analysis Report 2026-2036, Profiles of Leading Players - Dompe Farmaceutici, Bausch Health, Merck, Pfizer, and Glenmark Pharmaceuticals
globenewswire.com
BDX
MRK
PFE